A cross-disease, pleiotropy-driven approach for therapeutic target prioritization and evaluation

Chaohui Bao, Tingting Tan, Shan Wang, Chenxu Gao, Chang Lu, Siyue Yang, Yizhu Diao, Lulu Jiang, Duohui Jing, Liye Chen*, Haitao Lv*, Hai Fang*

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

14 Downloads (Pure)

Abstract

Cross-disease genome-wide association studies (GWASs) unveil pleiotropic loci, mostly situated within the non-coding genome, each of which exerts pleiotropic effects across multiple diseases. However, the challenge ‘‘W-H-W’’ (namely, whether, how, and in which specific diseases pleiotropy can inform clinical therapeutics) calls for effective and integrative approaches and tools. We here introduce a pleiotropy-driven approach specifically designed for therapeutic target prioritization and evaluation from cross-disease GWAS summary data, with its validity demonstrated through applications to two systems of disorders (neuropsychiatric and inflammatory). We illustrate its improved performance in recovering clinical proofof-concept therapeutic targets. Importantly, it identifies specific diseases where pleiotropy informs clinical therapeutics. Furthermore, we illustrate its versatility in accomplishing advanced tasks, including pathway crosstalk identification and downstream crosstalk-based analyses. To conclude, our integrated solution helps bridge the gap between pleiotropy studies and therapeutics discovery.
Original languageEnglish
Article number100757
Number of pages21
JournalCell Reports Methods
Volume4
Issue number4
Early online date16 Apr 2024
DOIs
Publication statusPublished - 22 Apr 2024

Scopus Subject Areas

  • Genetics
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)
  • Biochemistry
  • Radiology Nuclear Medicine and imaging
  • Biotechnology
  • Computer Science Applications

User-Defined Keywords

  • Cross-disease pleiotropic association data
  • computational medicine
  • inflammatory disorders
  • neuropsychiatric disorders
  • pleiotropy informing prioritization and evaluation
  • therapeutic targets

Fingerprint

Dive into the research topics of 'A cross-disease, pleiotropy-driven approach for therapeutic target prioritization and evaluation'. Together they form a unique fingerprint.

Cite this